[ Price : $8.95]
FDA issues Beta Bionics a Warning Letter, citing wide-ranging quality system, complaint handling, reporting, and recall-related vi...[ Price : $8.95]
BioMarin decides to voluntarily withdraw from the market its Roctavian (valoctocogene roxaparvovec-rvox) gene therapy for treating...[ Price : $8.95]
AdvaMed urges federal health officials to keep FDA at the center of oversight for artificial intelligence tools used in patient ca...[ Price : $8.95]
FDA issues a Warning Letter to A. Nelson & Co. Ltd., citing significant current good manufacturing practice violations and raising...[ Price : $8.95]
Johnson & Johnson files a supplemental BLA seeking approval of Imaavy as a treatment for warm autoimmune hemolytic anemia.[ Price : $8.95]
FDA issues a draft guidance entitled Considerations for the Use of the Plausible Mechanism Framework to Develop Individualized The...[ Price : $8.95]
FDA approves AstraZenecas Calquence (acalabrutinib) for use in combination with AbbVie and Genentechs Venclexta (venetoclax), a ch...[ Price : $8.95]
Novo Nordisk says its experimental obesity drug CagriSema delivered substantial weight loss in a head-to-head late-stage trial but...